During the past decade, Providence Cancer Institute Clackamas Clinic conducted 161 clinical trials. In the 10-year time frame, 161 clinical trials started and 53 clinical trials were completed, i.e. on average, 32.9% percent of trials that started reached the finish line to date. In the past 5 years, 74 clinical trials started and 50 clinical trials were completed. i.e. 67.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Providence Cancer Institute Clackamas Clinic" #1 sponsor was "National Cancer Institute (NCI)" with 91 trials, followed by "Alliance for Clinical Trials in Oncology" with 32 trials sponsored, "SWOG Cancer Research Network" with 31 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 16 trials sponsored and "NRG Oncology" with 16 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Providence Cancer Institute Clackamas Clinic" #1 collaborator was "National Cancer Institute (NCI)" with 94 trials as a collaborator, "NRG Oncology" with 17 trials as a collaborator, "Canadian Cancer Trials Group" with 9 trials as a collaborator, "Genentech, Inc." with 3 trials as a collaborator and "Astellas Pharma Inc" with 2 trials as a collaborator. Other collaborators include 19 different institutions and companies that were collaborators in the rest 27 trials.

According to Clinical.Site data, the most researched conditions in "Providence Cancer Institute Clackamas Clinic" are "Invasive Breast Carcinoma" (9 trials), "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "Recurrent Breast Carcinoma" (6 trials) and "Recurrent Ovarian Carcinoma" (6 trials). Many other conditions were trialed in "Providence Cancer Institute Clackamas Clinic" in a lesser frequency.

Most popular intervention types in "Providence Cancer Institute Clackamas Clinic" are "Drug" (153 trials), "Other" (110 trials), "Biological" (89 trials), "Procedure" (62 trials) and "Radiation" (23 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (51 trials), "Laboratory Biomarker Analysis" (46 trials), "Computed Tomography" (39 trials), "Questionnaire Administration" (36 trials) and "Biospecimen Collection" (35 trials). Other intervention names were less common.

The vast majority of trials in "Providence Cancer Institute Clackamas Clinic" are 159 trials for "All" genders, 28 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Providence Cancer Institute Clackamas Clinic". undefined are not yet recruiting, 68 are recruiting, 90 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Providence Cancer Institute Clackamas Clinic, 7 suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Providence Cancer Institute Clackamas Clinic, 7 "Phase 1" clinical trials were conducted, 100 "Phase 2" clinical trials and 97 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".